From: Choroidal manifestations of non-ocular sarcoidosis: an enhanced depth imaging OCT study
 | Control (mean ± SD or N [%]) | Non-ocular sarcoidosis (mean ± SD or N [%]) | p |
---|---|---|---|
Number of eyes | 30 eyes of 30 patients | 30 eyes of 30 patients | Â |
Demographics | |||
 Age, years | 56.00 ± 11.66 | 55.13 ± 11.58 | 0.874 |
 Sex, Male | 11 (36.66) | 11 (36.66) | 1.000 |
  Female | 19 (63.33) | 19 (63.33) |  |
 Subtypes of sarcoidosis |  | Pulmonary (27 [90]), Extrapulmonary; skin (3 [10]) |  |
 Duration of sarcoidosis, months |  | 16.10 ± 26.18 |  |
 Treatment regimen |  | Prednisolone (6 [20]), MTX (5 [16.66]), Observation (19 [63.63]) |  |
 ACE, U/L |  | 51.55 ± 21.77 |  |
 CRP, mg/dL |  | 0.20 ± 0.16 |  |
Ocular characteristics | |||
 BCVA, logMAR | 0.02 ± 0.04 | 0.03 ± 0.05 | 0.152 |
 SE, Diopters | -0.80 ± 1.81 | -0.71 ± 1.93 | 0.837 |
 IOP, mmHg | 16.06 ± 1.96 | 15.73 ± 2.40 | 0.559 |